[TAANN] QoQ Annualized Quarter Result on 31-Mar-2017 [#1]

Stock
[TAANN] TA ANN HOLDINGS BHD
Announcement Date
23-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 19.77%
YoY- 190.35%
Quarter Report
Latest QR
Upcoming QR
TAANN's Result
TAANN's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 1,172,939 1,173,470 1,143,864 1,222,264 1,147,072 1,116,662 975,226 13.05%
PBT 197,497 219,322 230,652 230,220 176,430 177,972 115,056 43.22%
Tax -56,339 -67,693 -63,770 -74,012 -45,326 -41,025 -24,866 72.24%
NP 141,158 151,629 166,882 156,208 131,104 136,946 90,190 34.69%
-
NP to SH 119,252 127,748 145,442 145,696 121,649 124,824 83,114 27.12%
-
Tax Rate 28.53% 30.86% 27.65% 32.15% 25.69% 23.05% 21.61% -
Total Cost 1,031,781 1,021,841 976,982 1,066,056 1,015,968 979,716 885,036 10.73%
-
Net Worth 1,338,980 1,325,042 1,329,488 889,290 1,271,623 1,258,345 1,200,541 7.52%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 44,484 59,285 88,929 88,929 44,462 59,285 44,464 0.02%
Div Payout % 37.30% 46.41% 61.14% 61.04% 36.55% 47.50% 53.50% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 1,338,980 1,325,042 1,329,488 889,290 1,271,623 1,258,345 1,200,541 7.52%
NOSH 444,645 444,645 444,645 444,645 444,645 444,645 444,645 0.00%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 12.03% 12.92% 14.59% 12.78% 11.43% 12.26% 9.25% -
ROE 8.91% 9.64% 10.94% 16.38% 9.57% 9.92% 6.92% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 263.67 263.91 257.25 274.89 257.99 251.14 219.33 13.02%
EPS 26.82 28.73 32.70 32.76 27.36 28.07 18.70 27.09%
DPS 10.00 13.33 20.00 20.00 10.00 13.33 10.00 0.00%
NAPS 3.01 2.98 2.99 2.00 2.86 2.83 2.70 7.49%
Adjusted Per Share Value based on latest NOSH - 444,645
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 266.37 266.49 259.76 277.57 260.49 253.59 221.47 13.05%
EPS 27.08 29.01 33.03 33.09 27.63 28.35 18.87 27.14%
DPS 10.10 13.46 20.20 20.20 10.10 13.46 10.10 0.00%
NAPS 3.0407 3.0091 3.0192 2.0195 2.8878 2.8576 2.7263 7.52%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 3.66 3.70 3.54 3.73 3.95 3.58 3.30 -
P/RPS 1.39 1.40 1.38 1.36 1.53 1.43 1.50 -4.93%
P/EPS 13.65 12.88 10.82 11.38 13.99 12.75 17.65 -15.70%
EY 7.32 7.76 9.24 8.78 7.15 7.84 5.66 18.64%
DY 2.73 3.60 5.65 5.36 2.53 3.72 3.03 -6.69%
P/NAPS 1.22 1.24 1.18 1.87 1.38 1.27 1.22 0.00%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 28/02/18 28/11/17 22/08/17 23/05/17 28/02/17 21/11/16 29/08/16 -
Price 3.43 3.56 3.47 3.51 3.88 3.64 3.64 -
P/RPS 1.30 1.35 1.35 1.28 1.50 1.45 1.66 -15.00%
P/EPS 12.79 12.39 10.61 10.71 13.74 12.97 19.47 -24.37%
EY 7.82 8.07 9.43 9.34 7.28 7.71 5.14 32.17%
DY 2.92 3.75 5.76 5.70 2.58 3.66 2.75 4.06%
P/NAPS 1.14 1.19 1.16 1.76 1.35 1.29 1.35 -10.63%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment